Quarterly snapshots from biopharma companies with marketed products, including: United Therapeutics, Ultragenyx.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aprinoia, Astellas, Astrazeneca, Daiichi Sankyo, Insmed, Passage, Qualigen, Revision, Taysha Gene Therapies.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerie, Agex, Alkido, Basilea, Bioprojet SCR, Bristol, Cara, Cerevel, Citrine, Covax, Eli Lilly, Endos, Enteris, Glaxosmithkline, Imstem, Indapta, Insitro, JT Pharmaceuticals, Novartis, Pandion, Phagomed, Puretech, Releviate, Rubius, Sanofi, Santen, Seagen, Spartina, Titan, Xoma.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Allergan, Alx, Ampio, Aurinia, Boehringer, Castle Creek, Clinuvel, Finch, Galera, Gyroscope, Highlight, Orasis, Mediwound, Regentree, Therapeutics Solutions.

Biopharmas raising money in public or private financings, including: Allakos, Eucrates, Gracell, Mirati, Scholar Rock, Senda, Ultragenyx.

New hires and promotions in the biopharma industry, including: Dr. Reddy's, Gentibio, Nervgen, Rhythm, Synspira, Stream, Synklino, Union.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Canbridge Pharmaceuticals, Pharmaessentia, Taiwan Liposome.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Sunshine Biopharma.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 4D, Amyris, Atriva, Bioinvent International, Biovaxys Technology, Chelation Partners, CNS, Contrafect, Curevac, Cytovant Sciences HK, Daiichi Sankyo, Dinona, Entos, Geovax Labs, Hemoshear, Immunic, Incelldx, Innocan, Kamada, Kedrion Biopharma, Medicago, Medigene, Medipharm Labs, Merck & Co., Moderna, Nascent, Neumentum, Nevakar, Nuance, Oric, Parexel International, Peptc Vaccines, Poseida, Precision Nanosystems, PTC, Resverlogix, Roche, Samsung Biologics, SOM, Synairgen, Takeda, Tetra, Tscan, Union, Voronoi, Zhaoke Ophthalmology.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Ascentage, Astrazeneca, Evgen, Gilead Sciences, Nicox, Nitric Oxide Innovations, Ocumension, PTC, Reven, Roche.